- Home
- GDO vs ZYXI Comparison
GDO vs ZYXI Comparison
Compare GDO & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDO
- ZYXI
- Stock Information
- Founded
- GDO 2009
- ZYXI 1996
- Country
- GDO United States
- ZYXI United States
- Employees
- GDO N/A
- ZYXI N/A
- Industry
- GDO Finance Companies
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GDO Finance
- ZYXI Health Care
- Exchange
- GDO Nasdaq
- ZYXI Nasdaq
- Market Cap
- GDO 82.4M
- ZYXI 66.5M
- IPO Year
- GDO N/A
- ZYXI N/A
- Fundamental
- Price
- GDO $11.13
- ZYXI $2.18
- Analyst Decision
- GDO
- ZYXI Buy
- Analyst Count
- GDO 0
- ZYXI 3
- Target Price
- GDO N/A
- ZYXI $10.25
- AVG Volume (30 Days)
- GDO 39.4K
- ZYXI 262.3K
- Earning Date
- GDO 01-01-0001
- ZYXI 04-29-2025
- Dividend Yield
- GDO 9.81%
- ZYXI N/A
- EPS Growth
- GDO N/A
- ZYXI N/A
- EPS
- GDO N/A
- ZYXI 0.09
- Revenue
- GDO N/A
- ZYXI $192,354,000.00
- Revenue This Year
- GDO N/A
- ZYXI N/A
- Revenue Next Year
- GDO N/A
- ZYXI $23.16
- P/E Ratio
- GDO N/A
- ZYXI $24.22
- Revenue Growth
- GDO N/A
- ZYXI 4.36
- 52 Week Low
- GDO $11.21
- ZYXI $1.93
- 52 Week High
- GDO $13.04
- ZYXI $12.19
- Technical
- Relative Strength Index (RSI)
- GDO 48.51
- ZYXI 26.14
- Support Level
- GDO $10.42
- ZYXI $2.03
- Resistance Level
- GDO $11.03
- ZYXI $2.24
- Average True Range (ATR)
- GDO 0.28
- ZYXI 0.18
- MACD
- GDO -0.00
- ZYXI 0.17
- Stochastic Oscillator
- GDO 62.69
- ZYXI 38.46
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.